Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Therapy of Early Stage Myelodysplastic Syndrome (MDS) With ATG and Etanercept
Brief Summary:
RATIONALE: Biological therapies, such as anti-thymocyte globulin and etanercept, may stimulate the immune system in different ways and stop cancer cells from growing. Giving anti-thymocyte globulin together with etanercept may kill more cancer cells.
PURPOSE: This phase II trial is studying how well giving anti-thymocyte globulin together with etanercept works in treating patients with myelodysplastic syndromes.